|
| [ На главную ] -- [ Список участников ] -- [ Правила форума ] -- [ Зарегистрироваться ] |
| On-line: |
| Клуб болельщиков "Торпедо" Владимир / / YDrYQeRvqqgRIcgQq |
| Страницы: 1 |
|
| Автор | Сообщение |
|
Frances Гость |
Добавлено: 22-06-2022 21:55 |
|
Best Site good looking generic cefuroxime Karen Lu, M.D., of the University of Texas MD Anderson Cancer Center in Houston, led a study testing an ovarian cancer screening method that incorporates changes in CA125, a blood protein known as a tumor marker for the disease. The method involves two stages of testing and is designed to detect changes in CA125. |
| Страницы: 1 |
|
| Клуб болельщиков "Торпедо" Владимир / / YDrYQeRvqqgRIcgQq |